FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281297788> ?p ?o ?g. }

• W4281297788 abstract "The RIG-I-like receptor signaling pathway is crucial for producing type I interferon (IFN-I) against RNA viruses. The present study observed that viral infection increased annexin-A1 (ANXA1) expression, and ANXA1 then promoted RNA virus-induced IFN-I production. Compared to ANXA1 wild-type cells, ANXA1-/- knockout cells showed IFN-β production decreasing after viral stimulation. RNA virus stimulation induced ANXA1 to regulate IFN-β production through the TBK1-IRF3 axis but not through the NF-κB axis. ANXA1 also interacted with JAK1 and STAT1 to increase signal transduction induced by IFN-β or IFN-γ. We assessed the effect of ANXA1 on the replication of foot-and-mouth disease virus (FMDV) and found that ANXA1 inhibits FMDV replication dependent on IFN-I production. FMDV 3A plays critical roles in viral replication and host range. The results showed that FMDV 3A interacts with ANXA1 to inhibit its ability to promote IFN-β production. We also demonstrated that FMDV 3A inhibits the formation of ANXA1-TBK1 complex. These results indicate that ANXA1 positively regulates RNA virus-stimulated IFN-β production and FMDV 3A antagonizes ANXA1-promoted IFN-β production to modulate viral replication. IMPORTANCE FMDV is a pathogen that causes one of the world's most destructive and highly contagious animal diseases. The FMDV 3A protein plays a critical role in viral replication and host range. Although 3A is one of the viral proteins that influences FMDV virulence, its underlying mechanisms remain unclear. ANXA1 is involved in immune activation against pathogens. The present study demonstrated that FMDV increases ANXA1 expression, while ANXA1 inhibits FMDV replication. The results also showed that ANXA1 promotes RNA virus-induced IFN-I production through the IRF3 axis at VISA and TBK1 levels. ANXA1 was also found to interact with JAK1 and STAT1 to strengthen signal transduction induced by IFN-β and IFN-γ. 3A interacted with ANXA1 to inhibit ANXA1-TBK1 complex formation, thereby antagonizing the inhibitory effect of ANXA1 on FMDV replication. This study helps to elucidate the mechanism underlying the effect of the 3A protein on FMDV replication." @default.
• W4281297788 created "2022-05-24" @default.
• W4281297788 creator A5009157036 @default.
• W4281297788 creator A5010172716 @default.
• W4281297788 creator A5011116311 @default.
• W4281297788 creator A5012159354 @default.
• W4281297788 creator A5016625146 @default.
• W4281297788 creator A5019541879 @default.
• W4281297788 creator A5042079141 @default.
• W4281297788 creator A5042855183 @default.
• W4281297788 creator A5058016330 @default.
• W4281297788 creator A5060017249 @default.
• W4281297788 creator A5061293375 @default.
• W4281297788 creator A5072757772 @default.
• W4281297788 creator A5081183372 @default.
• W4281297788 creator A5084603057 @default.
• W4281297788 creator A5091164735 @default.
• W4281297788 date "2022-06-22" @default.
• W4281297788 modified "2023-09-27" @default.
• W4281297788 title "FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication" @default.
• W4281297788 cites W1520032219 @default.
• W4281297788 cites W1533692689 @default.
• W4281297788 cites W1642847216 @default.
• W4281297788 cites W1893164196 @default.
• W4281297788 cites W1932669647 @default.
• W4281297788 cites W1966122707 @default.
• W4281297788 cites W1966167948 @default.
• W4281297788 cites W1968773176 @default.
• W4281297788 cites W1972811309 @default.
• W4281297788 cites W1980871234 @default.
• W4281297788 cites W1981110996 @default.
• W4281297788 cites W2003778885 @default.
• W4281297788 cites W2007187117 @default.
• W4281297788 cites W2037691295 @default.
• W4281297788 cites W2044574821 @default.
• W4281297788 cites W2060999580 @default.
• W4281297788 cites W2089510415 @default.
• W4281297788 cites W2090307950 @default.
• W4281297788 cites W2099003198 @default.
• W4281297788 cites W2107345125 @default.
• W4281297788 cites W2124877471 @default.
• W4281297788 cites W2141013019 @default.
• W4281297788 cites W2148240014 @default.
• W4281297788 cites W2157356426 @default.
• W4281297788 cites W2167726822 @default.
• W4281297788 cites W2288866881 @default.
• W4281297788 cites W2462891611 @default.
• W4281297788 cites W2485564204 @default.
• W4281297788 cites W2791422216 @default.
• W4281297788 cites W2808665779 @default.
• W4281297788 cites W2849426301 @default.
• W4281297788 cites W2896189613 @default.
• W4281297788 cites W2901828690 @default.
• W4281297788 cites W2968050800 @default.
• W4281297788 cites W2986560850 @default.
• W4281297788 cites W3032134073 @default.
• W4281297788 cites W3035133502 @default.
• W4281297788 cites W3107417040 @default.
• W4281297788 doi "https://doi.org/10.1128/jvi.00317-22" @default.
• W4281297788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35604142" @default.
• W4281297788 hasPublicationYear "2022" @default.
• W4281297788 type Work @default.
• W4281297788 citedByCount "5" @default.
• W4281297788 countsByYear W42812977882022 @default.
• W4281297788 countsByYear W42812977882023 @default.
• W4281297788 crossrefType "journal-article" @default.
• W4281297788 hasAuthorship W4281297788A5009157036 @default.
• W4281297788 hasAuthorship W4281297788A5010172716 @default.
• W4281297788 hasAuthorship W4281297788A5011116311 @default.
• W4281297788 hasAuthorship W4281297788A5012159354 @default.
• W4281297788 hasAuthorship W4281297788A5016625146 @default.
• W4281297788 hasAuthorship W4281297788A5019541879 @default.
• W4281297788 hasAuthorship W4281297788A5042079141 @default.
• W4281297788 hasAuthorship W4281297788A5042855183 @default.
• W4281297788 hasAuthorship W4281297788A5058016330 @default.
• W4281297788 hasAuthorship W4281297788A5060017249 @default.
• W4281297788 hasAuthorship W4281297788A5061293375 @default.
• W4281297788 hasAuthorship W4281297788A5072757772 @default.
• W4281297788 hasAuthorship W4281297788A5081183372 @default.
• W4281297788 hasAuthorship W4281297788A5084603057 @default.
• W4281297788 hasAuthorship W4281297788A5091164735 @default.
• W4281297788 hasBestOaLocation W42812977881 @default.
• W4281297788 hasConcept C104317684 @default.
• W4281297788 hasConcept C136449434 @default.
• W4281297788 hasConcept C140704245 @default.
• W4281297788 hasConcept C159047783 @default.
• W4281297788 hasConcept C203014093 @default.
• W4281297788 hasConcept C2522874641 @default.
• W4281297788 hasConcept C2776178377 @default.
• W4281297788 hasConcept C2780209191 @default.
• W4281297788 hasConcept C54355233 @default.
• W4281297788 hasConcept C67705224 @default.
• W4281297788 hasConcept C68246026 @default.
• W4281297788 hasConcept C81885089 @default.
• W4281297788 hasConcept C86803240 @default.
• W4281297788 hasConcept C88634738 @default.
• W4281297788 hasConcept C8891405 @default.
• W4281297788 hasConceptScore W4281297788C104317684 @default.
• W4281297788 hasConceptScore W4281297788C136449434 @default.
• W4281297788 hasConceptScore W4281297788C140704245 @default.

• next